Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biologics
Brought to you by:
Biotech
Allogene lays off 28% of staff to save cash amid program delays
The off-the-shelf CAR-T cell therapy specialist disclosed the changes alongside delays to two CAR-T milestones.
Nick Paul Taylor
May 14, 2025 8:00am
Kyverna lays off 16% as autoimmune CAR-T plans take shape
May 14, 2025 6:30am
Atara lays off more staff despite FDA lifting clinical hold
May 13, 2025 10:07am
Galapagos gets cold feet over plans to split up company
May 13, 2025 6:55am
Lexeo laid off 15% in April to focus on cardiac gene therapies
May 12, 2025 8:30am
Vor Bio to wind down, laying off most staff
May 8, 2025 10:50am
